Morgan Stanley Cuts 3SBIO (01530) Target Price to HK$34, Keeps "Overweight" Rating

Stock News

Apr 14

Morgan Stanley has released a research report incorporating 3SBIO's (01530) 2025 performance forecast. The report lowers the sales forecast and milestone payment expectations for the company's core commercial product TPIAO, primarily due to the impact of USD depreciation against the RMB. Consequently, Morgan Stanley has revised down its revenue forecasts for 3SBIO for the years 2026 to 2028 by 5%, 7%, and 6% respectively. The report also adjusts the product gross margin forecast based on recent trends and modifies the operating expense ratio. Earnings per share forecasts for the same period have been lowered by 8.3%, 14.5%, and 12.4% respectively. The target price has been reduced from HK$38 to HK$34, while the "Overweight" rating is maintained.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1164413996"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164413996\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164413996?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 11:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164413996","market":"other","top_or_hot":-1,"title":"Morgan Stanley Cuts 3SBIO (01530) Target Price to HK$34, Keeps \"Overweight\" Rating","media":"Stock News","content":"<p>Morgan Stanley has released a research report incorporating 3SBIO's (01530) 2025 performance forecast. The report lowers the sales forecast and milestone payment expectations for the company's core commercial product TPIAO, primarily due to the impact of USD depreciation against the RMB. Consequently, Morgan Stanley has revised down its revenue forecasts for 3SBIO for the years 2026 to 2028 by 5%, 7%, and 6% respectively. The report also adjusts the product gross margin forecast based on recent trends and modifies the operating expense ratio. Earnings per share forecasts for the same period have been lowered by 8.3%, 14.5%, and 12.4% respectively. The target price has been reduced from HK$38 to HK$34, while the \"Overweight\" rating is maintained.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Cuts 3SBIO (01530) Target Price to HK$34, Keeps \"Overweight\" Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Cuts 3SBIO (01530) Target Price to HK$34, Keeps \"Overweight\" Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-04-14 11:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Morgan Stanley has released a research report incorporating 3SBIO's (01530) 2025 performance forecast. The report lowers the sales forecast and milestone payment expectations for the company's core commercial product TPIAO, primarily due to the impact of USD depreciation against the RMB. Consequently, Morgan Stanley has revised down its revenue forecasts for 3SBIO for the years 2026 to 2028 by 5%, 7%, and 6% respectively. The report also adjusts the product gross margin forecast based on recent trends and modifies the operating expense ratio. Earnings per share forecasts for the same period have been lowered by 8.3%, 14.5%, and 12.4% respectively. The target price has been reduced from HK$38 to HK$34, while the \"Overweight\" rating is maintained.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1593","symbol_name":"医美概念股","start_time":0,"source_url":"","article_id":"1164413996","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164413996","pubTimestamp":1776138036,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Morgan Stanley has released a research report incorporating 3SBIO's (01530) 2025 performance forecast. The report lowers the sales forecast and milestone payment expectations for the company's core...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1593":"医美概念股","01530":"三生制药","EWH":"香港ETF-iShares MSCI","BK1583":"高瓴概念","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","BK1161":"生物科技"},"translate_title":"大摩下调三生制药(01530)目标价至34港元维持“跑赢大盘”评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1,"EWH":1},"content_text":"Morgan Stanley has released a research report incorporating 3SBIO's (01530) 2025 performance forecast. The report lowers the sales forecast and milestone payment expectations for the company's core commercial product TPIAO, primarily due to the impact of USD depreciation against the RMB. Consequently, Morgan Stanley has revised down its revenue forecasts for 3SBIO for the years 2026 to 2028 by 5%, 7%, and 6% respectively. The report also adjusts the product gross margin forecast based on recent trends and modifies the operating expense ratio. Earnings per share forecasts for the same period have been lowered by 8.3%, 14.5%, and 12.4% respectively. The target price has been reduced from HK$38 to HK$34, while the \"Overweight\" rating is maintained.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}